Table 1. Participants’ characteristics.
| Characteristics | Numbers of participants |
|---|---|
| Gender (male: female) | 21 male: 13 female |
| Age (years) (mean: range) | 72.2: 39–86 |
| Years since diagnosis (years) (mean: range) | 9.4: 0.5–49 |
| | |
|
Severity of COPD (GOLD)42 | |
| GOLD stage 1 (FEV1⩾80% predicted) | 10 |
| GOLD stage 2 (FEV1 50–79% predicted) | 10 |
| GOLD stage 3 (FEV1 30–49% predicted) | 9 |
| GOLD stage 4 (FEV1<30% predicted, or <50% predicted with chronic respiratory failure present) | 5 |
|
Health-related quality-of-life impact (COPD Assessment Test, CAT41) | |
| Low (CAT Score<10) | 8 |
| Medium (CAT Score 10–20) | 9 |
| High (CAT Score 20–30) | 8 |
| Very high (CAT Score>30) | 9 |
| Previous attendance at pulmonary rehabilitation | 10 |
|
Living conditions | |
| Alone: with spouse/family | 11: 23 |
| Accommodation type | 28 own home: 5 sheltered housing: 1 hostel |
| Working status | Unemployed: 1 |
| Part-time working: 2 | |
| Semi-retired: 2 | |
| Retired: 29 | |
| | |
|
Co-morbidities | |
| Number of participants with co-morbidity | 32 |
| Mean number: range | 3.4: 0–11 |
| Self-reported psychological co-morbidities (Numbers: receiving treatment (medication/psychological therapies) | |
| Any | 19: 6 |
| Anxiety | 13: 3 |
| Depression | 12: 5 |
| Anxiety and depression | 8: 3 |
Abbreviations: COPD, chronic obstructive pulmonary lung diseae; FEV1, forced expiratory volume in the first second; GOLD, Global Initiative for Chronic Obstructive Lung Disease.